“…As reported by others (Chimienti et al, 2001;Corniola et al, 2008;Bozym et al, 2010;Pang et al, 2012Pang et al, , 2013Strand et al, 2013), cleaved capase-3 (active caspase) was increased significantly in TPEN-treated cNCC. Zn is an endogenous inhibitor of CC3; removal of Zn from procaspase inhibitory binding sites results in the auto-proteolytic cleavage transformation of the zymogen into an active effector capase3 (Peterson et al, 2009;Daniel et al, 2014). This inhibition requires the maintenance of relatively high intracellular (nM) Zn ion concentrations (Maret et al, 1999;Maret, 2011).…”